[Ruthenium complexes as antitumor drugs: isolation of a new Ru (III) and iminodiacetic acid complex].
The authors discuss the convenience for using ruthenium complexes as potential antitumor drugs, and the considerable importance of these substances in regard to their biological activity. The synthesis of a new drug of the group and the results of its administration to mice bearing Ehrlich ascites cancer are reported.
D000818:Animals; D000970:Antineoplastic Agents; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy; D004353:Drug Evaluation, Preclinical; D007098:Imino Acids / Q000494:pharmacology*; D051379:Mice; D012428:Ruthenium / Q000378:metabolism / Q000494:pharmacology*
D000970:Antineoplastic Agents; D007098:Imino Acids; C051005:iminodiacetic acid-ruthenium (III) complex; D012428:Ruthenium
Complejos de rutenio como drogas antitumorales: aislamiento de un nuevo compuesto de Ru (III) y AID.